Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA supplement brochure

This article was originally published in The Tan Sheet

Executive Summary

A joint CFSAN/ODS brochure titled "What Dietary Supplements Are You Taking? Does Your Health Care Provider Know? It Matters, and Here's Why" offers tools to guide patients conversations about dietary supplements with their healthcare providers. A Nutrition Assessment checklist first helps patients evaluate whether supplement use is appropriate based on their diets, while a supplement diary sets up a scheme to record all the supplements a patient takes. A medication diary encourages patients to list all current Rx and OTC medications. The brochure text twice reminds readers to "not substitute a dietary supplement for a prescription medicine or therapy," and that "some supplements can have unwanted effects before, during and after surgery." The agency had 50,000 copies of the brochure printed, and has distributed roughly 10,000 to date...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098278

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel